Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.68 |
| ▸ | HTR2A | P28223 | 6/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.50 |
| ▸ | HTR2C | P28335 | 3/20 | 0.50 |
| ▸ | HTR2B | P41595 | 3/20 | 0.50 |
| ▸ | PAM | P19021 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7514298 | 1.00 | IDO1 (0.68) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL430935 | 1.00 | IDO1 (0.68) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL7254873 | 0.91 | IDO1 (0.63) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL7254870 | 0.91 | IDO1 (0.63) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL20127256 | 0.91 | IDO1 (0.63) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| Catechol SCHEMBL10615010 | 0.89 | IDO1 (0.57) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL1158122 | 0.89 | IDO1 (0.57) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| Catechol SCHEMBL10615001 | 0.89 | IDO1 (0.57) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL1158123 | 0.89 | IDO1 (0.57) | IDO1HTR2ASIGMAR1HTR2CHTR2B | |
| SCHEMBL10624030 | 0.89 | IDO1 (0.62) | IDO1HTR2ASIGMAR1HTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024119101-A1 | STIMULI-RESPONSIVE TRACELESS ENGINEERING PLATFORM FOR INTRACELLULAR PAYLOAD DELIVERY | YALE UNIVERSITY (US) | 2024-06-06 | — | — | WO | claimed |
| US-8308892-B2 | Di-cinnamyl compounds and methods for use thereof | DESIGNER MOLECULES, INC. (US) | 2012-11-13 | — | — | US | claimed |
| US-20090288768-A1 | DI-CINNAMYL COMPOUNDS AND METHODS FOR USE THEREOF | DESIGNER MOLECULES, INC. | 2009-11-26 | — | — | US | claimed |
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH & CIE (CH) | 2026-03-12 | — | — | US | disclosed |
| CN-121591684-A | Regulation and control method for catalyzing transfer hydrogenation and etherification of biomass-based aldehydes | 岭南师范学院 | 2026-03-03 | — | — | CN | disclosed |
| US-RE50800-E1 | Pro-fragrance compounds | FIRMENICH SA (CH) | 2026-02-17 | — | — | US | disclosed |
| EP-4604951-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | AMIRA THERAPEUTICS, S.L. (ES) | 2025-08-27 | — | — | EP | disclosed |
| US-12264295-B2 | Encapsulated pro-perfume compounds | FIRMENICH SA (CH) | 2025-04-01 | — | — | US | disclosed |
| US-20240350381-A1 | FRAGRANCES WITH IMPROVED LONG-LASTING PERFORMANCE | FIRMENICH SA (CH) | 2024-10-24 | — | — | US | disclosed |
| CN-115480016-B | Liquid chromatographic analysis and detection method of laurinol polyoxyethylene ether nonionic surfactant | 中国科学院兰州化学物理研究所 | 2024-09-17 | — | — | CN | disclosed |
| CN-118638826-A | Application of surfactant or nano-disc in synthesizing membrane protein in cell-free synthesis system | 清华大学 | 2024-09-13 | — | — | CN | disclosed |
| US-4839325-A | FLUORINATED, 2,4 PENTADIONE AND FATTY ACID METAL SALT; INCREASED POT LIFE | MONSANTO COMPANY (US) | 1989-06-13 | — | — | US | disclosed |
| US-4826923-A | Allyloxy activated surface coatings | MONSANTO COMPANY (US) | 1989-05-02 | — | — | US | disclosed |
| US-4816535-A | FREE RADICAL-POLYMERIZABLE COMPOUND, FUGITIVE ACID-STABILIZED METAL DRIER AND PEROXIDE INITIATOR | MONSANTO COMPANY (US) | 1989-03-28 | — | — | US | disclosed |
| US-4810757-A | MODERATED METAL DRIER | MONSANTO COMPANY (US) | 1989-03-07 | — | — | US | disclosed |
| EP-0296141-A2 | Allyloxy activated surface coatings | Monsanto Company (US) | 1988-12-21 | — | — | EP | disclosed |
| EP-0296140-A2 | Allyloxy-activated surface coatings | Monsanto Company (US) | 1988-12-21 | — | — | EP | disclosed |
| EP-0273025-A2 | Stabilized metal drier | MONSANTO COMPANY (US) | 1988-06-29 | — | — | EP | disclosed |
| US-4670308-A | FREE RADICAL POLYMERIZATION | MONSANTO COMPANY (US) | 1987-06-02 | — | — | US | disclosed |
| EP-0210158-A1 | Surface coating process | Monsanto Company (US) | 1987-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | CNOT9, MSL1, MT-CO2 | IDO1 638/4885HTR2A 2456/4885SIGMAR1 1863/4885 |
| US-20240350381-A1 | FRAGRANCES WITH IMPROVED LONG-LASTING PERFORMANCE | FABP5, FAAH2, FASN | IDO1 867/4885HTR2A 585/4885SIGMAR1 253/4885 |
| US-20090288768-A1 | DI-CINNAMYL COMPOUNDS AND METHODS FOR USE THEREOF | CAD, DBF4, ACMSD | IDO1 2736/4885HTR2A 4135/4885SIGMAR1 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.